Regulations.gov document
2023-001166 - Corporation Genacol Canada Inc. - Genacol Fast Action - Supports joint and…
Other · FDA-2023-S-0024 · posted Sep 21, 2023
Key facts
| Document ID | FDA-2023-S-0024-0541 |
|---|---|
| Title | 2023-001166 - Corporation Genacol Canada Inc. - Genacol Fast Action - Supports joint and muscle health post work out |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2023-S-0024 |
| Posted | Sep 21, 2023 |
| Comment period opens | Sep 21, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: